Anna Brockbank
Overview
Explore the profile of Anna Brockbank including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
34
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Valensin C, Cote E, Pereira-Carvalho D, Gardner R, Nishku G, Giles C, et al.
Reprod Health
. 2024 Nov;
21(1):177.
PMID: 39609862
Background: Pregnancy and early childhood cohorts provide a framework for investigating the complex interplay between early-life exposures and health outcomes, thereby informing prevention strategies and interventions to improve maternal and...
2.
Hurrell A, Webster L, Sparkes J, Battersby C, Brockbank A, Clark K, et al.
Hypertension
. 2024 May;
81(7):1561-1573.
PMID: 38708607
Background: PlGF (placental growth factor)-based testing reduces severe maternal adverse outcomes. Repeat PlGF-based testing is not associated with improved perinatal or maternal outcomes. This planned secondary analysis aimed to determine...
3.
Hurrell A, Webster L, Sparkes J, Battersby C, Brockbank A, Clark K, et al.
Lancet
. 2024 Feb;
403(10427):619-631.
PMID: 38342128
Background: Placental growth factor (PlGF)-based testing has high diagnostic accuracy for predicting pre-eclampsia needing delivery, significantly reducing time to diagnosis and severe maternal adverse outcomes. The clinical benefit of repeat...
4.
Mary S, Conti-Ramsden F, Boder P, Parveen H, Setjiadi D, Fleminger J, et al.
J Nephrol
. 2024 Jan;
37(3):597-610.
PMID: 38236469
Background: Pregnancy involves major adaptations in renal haemodynamics, tubular, and endocrine functions. Hypertensive disorders of pregnancy are a leading cause of maternal mortality and morbidity. Uromodulin is a nephron-derived protein...
5.
Andreeva D, Gill C, Brockbank A, Hejmej J, Conti-Ramsden F, Doores K, et al.
BJOG
. 2023 Apr;
130(9):1135-1144.
PMID: 37113111
Objective: To determine severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence in pregnancy in an inner-city setting and assess associations with demographic factors and vaccination timing. Design: Repeated cross-sectional surveillance...
6.
Chappell L, Brocklehurst P, Green M, Hardy P, Hunter R, Beardmore-Gray A, et al.
Health Technol Assess
. 2022 Dec;
PMID: 36547875
Background: In women with late preterm pre-eclampsia (i.e. at 34 to 36 weeks' gestation), the optimal delivery time is unclear because limitation of maternal-fetal disease progression needs to be balanced...
7.
Quotah O, Nishku G, Hunt J, Seed P, Gill C, Brockbank A, et al.
Pilot Feasibility Stud
. 2022 Mar;
8(1):70.
PMID: 35337389
Background: Obesity in pregnancy increases the risk of gestational diabetes mellitus (GDM) and associated adverse outcomes. Despite metabolic differences, all pregnant women with obesity are considered to have the same...
8.
Duhig K, Seed P, Placzek A, Sparkes J, Gill C, Brockbank A, et al.
Health Technol Assess
. 2021 May;
25(30):1-32.
PMID: 34024312
Background: Pre-eclampsia affects around 2-3% of all pregnancies, and is associated with potential serious complications for the woman and the baby. Once diagnosed, progression of the syndrome can be unpredictable,...
9.
Duhig K, Seed P, Placzek A, Sparkes J, Hendy E, Gill C, et al.
Pregnancy Hypertens
. 2021 Mar;
24:90-95.
PMID: 33770588
Objective: To assess the diagnostic performance of angiogenic biomarkers in determining need for delivery in seven days in women with late preterm preeclampsia. Study Design: In a prospective observational cohort...
10.
Wiles K, Bramham K, Seed P, Brockbank A, Nelson-Piercy C, Karumanchi S, et al.
Pregnancy Hypertens
. 2021 Mar;
24:58-64.
PMID: 33677420
Objectives: To evaluate PlGF, sFlt-1, and novel endothelial biomarkers hyaluronan and vascular cell adhesion molecule (VCAM), for the prediction of superimposed pre-eclampsia in women with chronic kidney disease (CKD). Study...